{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:44:24Z","timestamp":1768344264215,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation Project","award":["2020GXNSFDA297014"],"award-info":[{"award-number":["2020GXNSFDA297014"]}]},{"name":"Innovative Research Team Project of Guangxi Natural Science Foundation","award":["2018GXNSFGA281006"],"award-info":[{"award-number":["2018GXNSFGA281006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Liver injury (LI) has been frequently observed in patients with dilated cardiomyopathy (DCM), whereas its prognostic value remains blurry. We attempted to appraise the prognostic effect of LI in patients with DCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study included 523 patients with DCM. LI was defined as a threefold increase in aspartate transaminase (\u2265\u2009135\u00a0U\/L) or alanine transaminase (\u2265\u2009180\u00a0U\/L) or a twofold increase in total bilirubin (\u2265\u200941\u00a0umol\/L) during hospitalization. The population was segmented into non-liver injury (NLI) group and LI group based on liver function test data. To balance differences in covariates at baseline, 1:1 propensity score matching (PSM) was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with LI had lower survival rate, compared with those with NLI (44.6% vs. 73.8%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Similar results were also found in age (age\u2009&gt;\u200950, 39.6% vs. 70.9%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; age\u2009\u2264\u200950, 51.3% vs. 79.5%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and gender stratified analysis (male, 46.2% vs. 74.4%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; female 35.7% vs. 72.0%, <jats:italic>P<\/jats:italic>\u2009=\u20090.001). After PSM, the survival rate of patients with LI remained lower than those with NLI (44.6% vs. 64.1%, <jats:italic>P<\/jats:italic>\u2009=\u20090.019). Multivariable Cox regression analysis manifested that LI (hazard ratio [HR]: 1.692, 95% confidence interval [CI] 1.194\u20132.398, <jats:italic>P<\/jats:italic>\u2009=\u20090.003; HR: 1.675, 95% CI 1.078\u20132.604, <jats:italic>P<\/jats:italic>\u2009=\u20090.022, respectively) showed potent predictive effect on all-cause mortality in patients with DCM, both before and after PSM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The occurrence of LI herald adverse outcomes in patients with DCM and attention to LI may be conducive to risk stratification and management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-022-00876-9","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:03:13Z","timestamp":1667894593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic potential of liver injury in patients with dilated cardiomyopathy: a retrospective study"],"prefix":"10.1186","volume":"27","author":[{"given":"Hai-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"3","key":"876_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1172\/jci100272","volume":"8","author":"N Jolliffe","year":"1930","unstructured":"Jolliffe N. Liver function in congestive heart failure. J Clin Invest. 1930;8(3):419\u201333. https:\/\/doi.org\/10.1172\/jci100272.","journal-title":"J Clin Invest"},{"issue":"3","key":"876_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/tjg.2015.0086","volume":"26","author":"K Cagli","year":"2015","unstructured":"Cagli K, Basar FN, Tok D, Turak O, Basar O. How to interpret liver function tests in heart failure patients? Turk J Gastroenterol. 2015;26(3):197\u2013203. https:\/\/doi.org\/10.5152\/tjg.2015.0086.","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"876_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/hep.30824","volume":"70","author":"T Horvatits","year":"2019","unstructured":"Horvatits T, Drolz A, Trauner M, Fuhrmann V. Liver injury and failure in critical illness. Hepatology. 2019;70(6):2204\u201315. https:\/\/doi.org\/10.1002\/hep.30824.","journal-title":"Hepatology"},{"issue":"7","key":"876_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ejhf.532","volume":"18","author":"J Biegus","year":"2016","unstructured":"Biegus J, Hillege HL, Postmus D, Valente MA, Bloomfield DM, Cleland JG, et al. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. Eur J Heart Fail. 2016;18(7):830\u20139. https:\/\/doi.org\/10.1002\/ejhf.532.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"876_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.20452\/pamw.1413","volume":"122","author":"J Biegus","year":"2012","unstructured":"Biegus J, Zymli\u0144ski R, Sokolski M, Nawrocka S, Siwo\u0142owski P, Szachniewicz J, et al. Liver function tests in patients with acute heart failure. Pol Arch Med Wewn. 2012;122(10):471\u20139. https:\/\/doi.org\/10.20452\/pamw.1413.","journal-title":"Pol Arch Med Wewn"},{"issue":"2","key":"876_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","volume":"11","author":"LA Allen","year":"2009","unstructured":"Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170\u20137. https:\/\/doi.org\/10.1093\/eurjhf\/hfn031.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"876_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/oxfordjournals.eurheartj.a060785","volume":"16","author":"P Batin","year":"1995","unstructured":"Batin P, Wickens M, McEntegart D, Fullwood L, Cowley AJ. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J. 1995;16(11):1613\u20138. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a060785.","journal-title":"Eur Heart J"},{"key":"876_CR8","doi-asserted-by":"publisher","first-page":"618816","DOI":"10.3389\/fcvm.2021.618816","volume":"8","author":"W Liang","year":"2021","unstructured":"Liang W, He X, Wu D, Xue R, Dong B, Owusu-Agyeman M, et al. Prognostic implication of liver function tests in heart failure with preserved ejection fraction without chronic hepatic diseases: insight from TOPCAT Trial. Front Cardiovasc Med. 2021;8:618816. https:\/\/doi.org\/10.3389\/fcvm.2021.618816.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"876_CR9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejhf.1853","volume":"22","author":"K Suzuki","year":"2020","unstructured":"Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Rouleau J, et al. Liver function and prognosis, and influence of sacubitril\/valsartan in patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2020;22(9):1662\u201371. https:\/\/doi.org\/10.1002\/ejhf.1853.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"876_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cardfail.2014.03.003","volume":"20","author":"VM van Deursen","year":"2014","unstructured":"van Deursen VM, Edwards C, Cotter G, Davison BA, Damman K, Teerlink JR, et al. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. J Card Fail. 2014;20(6):407\u201313. https:\/\/doi.org\/10.1016\/j.cardfail.2014.03.003.","journal-title":"J Card Fail"},{"issue":"3","key":"876_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3904\/kjim.2013.28.3.300","volume":"28","author":"J Chintanaboina","year":"2013","unstructured":"Chintanaboina J, Haner MS, Sethi A, Patel N, Tanyous W, Lalos A, et al. Serum bilirubin as a prognostic marker in patients with acute decompensated heart failure. Korean J Intern Med. 2013;28(3):300\u20135. https:\/\/doi.org\/10.3904\/kjim.2013.28.3.300.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"876_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","volume":"42","author":"G Poelzl","year":"2012","unstructured":"Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest. 2012;42(2):153\u201363. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02573.x.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"876_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","volume":"14","author":"AP Ambrosy","year":"2012","unstructured":"Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012;14(3):302\u201311. https:\/\/doi.org\/10.1093\/eurjhf\/hfs007.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"876_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241\u201357. https:\/\/doi.org\/10.1038\/nrneph.2017.2.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"876_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/gast.2002.36061","volume":"123","author":"RM Green","year":"2002","unstructured":"Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367\u201384. https:\/\/doi.org\/10.1053\/gast.2002.36061.","journal-title":"Gastroenterology"},{"issue":"5","key":"876_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","volume":"116","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR, Practice Parameters Committee of the American College of G. ACG Clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116(5):878\u201398. https:\/\/doi.org\/10.14309\/ajg.0000000000001259.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"876_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cld.2009.02.001","volume":"13","author":"M Krier","year":"2009","unstructured":"Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis. 2009;13(2):167\u201377. https:\/\/doi.org\/10.1016\/j.cld.2009.02.001.","journal-title":"Clin Liver Dis"},{"issue":"9","key":"876_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3748\/wjg.v27.i9.835","volume":"27","author":"SS Zhang","year":"2021","unstructured":"Zhang SS, Dong L, Wang GM, Tian Y, Ye XF, Zhao Y, et al. Progressive liver injury and increased mortality risk in COVID-19 patients: a retrospective cohort study in China. World J Gastroenterol. 2021;27(9):835\u201353. https:\/\/doi.org\/10.3748\/wjg.v27.i9.835.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"876_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"876_CR20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440\u201363. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"876_CR21","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/asn.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344. https:\/\/doi.org\/10.1681\/asn.2006040368.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"876_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1103","volume":"20","author":"M Merlo","year":"2018","unstructured":"Merlo M, Cannat\u00e0 A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228\u201339. https:\/\/doi.org\/10.1002\/ejhf.1103.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"876_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4065\/81.9.1232","volume":"81","author":"EC Ebert","year":"2006","unstructured":"Ebert EC. Hypoxic liver injury. Mayo Clin Proc. 2006;81(9):1232\u20136. https:\/\/doi.org\/10.4065\/81.9.1232.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"876_CR24","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1152\/ajplegacy.1969.216.6.1441","volume":"216","author":"J Shorey","year":"1969","unstructured":"Shorey J, Schenker S, Combes B. Effect of acute hypoxia on hepatic excretory function. Am J Physiol. 1969;216(6):1441\u201352. https:\/\/doi.org\/10.1152\/ajplegacy.1969.216.6.1441.","journal-title":"Am J Physiol"},{"issue":"5","key":"876_CR25","first-page":"527","volume":"41","author":"AJ Reese","year":"1960","unstructured":"Reese AJ. The effect of hypoxia on liver secretion studied by intravital fluorescence microscopy. Br J Exp Pathol. 1960;41(5):527\u201335.","journal-title":"Br J Exp Pathol"},{"issue":"2","key":"876_CR26","first-page":"317","volume":"10","author":"MR Kramer","year":"1991","unstructured":"Kramer MR, Marshall SE, Tiroke A, Lewiston NJ, Starnes VA, Theodore J. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation. J Heart Lung Transplant. 1991;10(2):317\u201321.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"876_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00075198-200304000-00008","volume":"9","author":"EP Ceppa","year":"2003","unstructured":"Ceppa EP, Fuh KC, Bulkley GB. Mesenteric hemodynamic response to circulatory shock. Curr Opin Crit Care. 2003;9(2):127\u201332. https:\/\/doi.org\/10.1097\/00075198-200304000-00008.","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"876_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/hep.510290202","volume":"29","author":"J Henrion","year":"1999","unstructured":"Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology. 1999;29(2):427\u201333. https:\/\/doi.org\/10.1002\/hep.510290202.","journal-title":"Hepatology"},{"issue":"2","key":"876_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0039-6060(96)80163-2","volume":"119","author":"RH Turnage","year":"1996","unstructured":"Turnage RH, Kadesky KM, Myers SI, Guice KS, Oldham KT. Hepatic hypoperfusion after intestinal reperfusion. Surgery. 1996;119(2):151\u201360. https:\/\/doi.org\/10.1016\/s0039-6060(96)80163-2.","journal-title":"Surgery"},{"issue":"5","key":"876_CR30","doi-asserted-by":"publisher","first-page":"G819","DOI":"10.1152\/ajpgi.2001.280.5.G819","volume":"280","author":"SM Jakob","year":"2001","unstructured":"Jakob SM, Tenhunen JJ, Laitinen S, Heino A, Alhava E, Takala J. Effects of systemic arterial hypoperusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol. 2001;280(5):G819\u201327.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"876_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijcard.2012.05.003","volume":"166","author":"A Kavoliuniene","year":"2013","unstructured":"Kavoliuniene A, Vaitiekiene A, Cesnaite G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist\u2019s point of view. Int J Cardiol. 2013;166(3):554\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2012.05.003.","journal-title":"Int J Cardiol"},{"issue":"2","key":"876_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.gtc.2017.01.012","volume":"46","author":"AK KoehnedeGonzalez","year":"2017","unstructured":"KoehnedeGonzalez AK, Lefkowitch JH. Heart disease and the liver: pathologic evaluation. Gastroenterol Clin N Am. 2017;46(2):421\u201335. https:\/\/doi.org\/10.1016\/j.gtc.2017.01.012.","journal-title":"Gastroenterol Clin N Am"},{"issue":"14","key":"876_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2169\/internalmedicine.46.0059","volume":"46","author":"R Birrer","year":"2007","unstructured":"Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med. 2007;46(14):1063\u201370. https:\/\/doi.org\/10.2169\/internalmedicine.46.0059.","journal-title":"Intern Med"},{"issue":"3","key":"876_CR34","doi-asserted-by":"publisher","first-page":"e007347","DOI":"10.1161\/CIRCHEARTFAILURE.120.007347","volume":"14","author":"X Rossello","year":"2021","unstructured":"Rossello X, Bueno H, Gil V, Jacob J, Martin-Sanchez FJ, Llorens P, et al. Synergistic impact of systolic blood pressure and perfusion status on mortality in acute heart failure. Circ Heart Fail. 2021;14(3):e007347. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007347.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"876_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/joim.12944","volume":"286","author":"D Reichart","year":"2019","unstructured":"Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature. J Intern Med. 2019;286(4):362\u201372. https:\/\/doi.org\/10.1111\/joim.12944.","journal-title":"J Intern Med"},{"issue":"23","key":"876_CR36","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv727.","journal-title":"Eur Heart J"},{"key":"876_CR37","unstructured":"Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. 2008."},{"issue":"7","key":"876_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","volume":"147","author":"SH Kubo","year":"1987","unstructured":"Kubo SH, Walter BA, John DH, Clark M, Cody RJ. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. 1987;147(7):1227\u201330.","journal-title":"Arch Intern Med"},{"issue":"1","key":"876_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","volume":"16","author":"VM van Deursen","year":"2010","unstructured":"van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010;16(1):84\u201390. https:\/\/doi.org\/10.1016\/j.cardfail.2009.08.002.","journal-title":"J Card Fail"},{"issue":"7","key":"876_CR40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cardfail.2014.05.001","volume":"20","author":"M Scholfield","year":"2014","unstructured":"Scholfield M, Schabath MB, Guglin M. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial. J Cardiac Fail. 2014;20(7):476\u201384. https:\/\/doi.org\/10.1016\/j.cardfail.2014.05.001.","journal-title":"J Cardiac Fail"},{"issue":"6","key":"876_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.1494","volume":"21","author":"C Mueller","year":"2019","unstructured":"Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715\u201331. https:\/\/doi.org\/10.1002\/ejhf.1494.","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"876_CR42","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1016\/j.jacc.2019.04.022","volume":"73","author":"C Arundel","year":"2019","unstructured":"Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, et al. Systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73(24):3054\u201363. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.022.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"876_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamacardio.2017.5365","volume":"3","author":"A Tsimploulis","year":"2018","unstructured":"Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, et al. Systolic blood pressure and outcomes in patients with heart failure with preserved ejection fraction. JAMA Cardiol. 2018;3(4):288\u201397. https:\/\/doi.org\/10.1001\/jamacardio.2017.5365.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"876_CR44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ehf2.13864","volume":"9","author":"J Feng","year":"2022","unstructured":"Feng J, Tian P, Liang L, Chen Y, Wang Y, Zhai M, et al. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy. ESC Heart Fail. 2022;9(3):1625\u201335. https:\/\/doi.org\/10.1002\/ehf2.13864.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"876_CR45","doi-asserted-by":"publisher","first-page":"e001193","DOI":"10.1161\/jaha.114.001193","volume":"3","author":"K Narayanan","year":"2014","unstructured":"Narayanan K, Reinier K, Teodorescu C, Uy-Evanado A, Aleong R, Chugh H, et al. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc. 2014;3(5):e001193. https:\/\/doi.org\/10.1161\/jaha.114.001193.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"876_CR46","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","volume":"336","author":"RS Vasan","year":"1997","unstructured":"Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997;336(19):1350\u20135.","journal-title":"N Engl J Med"},{"key":"876_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2020.08.062","volume":"323","author":"V Nuzzi","year":"2021","unstructured":"Nuzzi V, Cannat\u00e0 A, Manca P, Castrichini M, Barbati G, Aleksova A, et al. Atrial fibrillation in dilated cardiomyopathy: outcome prediction from an observational registry. Int J Cardiol. 2021;323:140\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.062.","journal-title":"Int J Cardiol"},{"issue":"3","key":"876_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","volume":"11","author":"S Wiese","year":"2014","unstructured":"Wiese S, Hove JD, Bendtsen F, Moller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014;11(3):177\u201386. https:\/\/doi.org\/10.1038\/nrgastro.2013.210.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"24","key":"876_CR49","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","volume":"61","author":"MD Samsky","year":"2013","unstructured":"Samsky MD, Patel CB, DeWald TA, Smith AD, Felker GM, Rogers JG, et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol. 2013;61(24):2397\u2013405. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.042.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"876_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","volume":"161","author":"T Kato","year":"2012","unstructured":"Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A, et al. Analysis of liver metabolism in a rat model of heart failure. Int J Cardiol. 2012;161(3):130\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2011.07.056.","journal-title":"Int J Cardiol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00876-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:09:57Z","timestamp":1667894997000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00876-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00876-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Human Research Ethics Committee of the First Affiliated Hospital of Guangxi Medical University [NO. 2022-KY-E-(280)] and the requirement for informed consent was waived because of the retrospective nature of the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}